Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study

about

Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study

Item

http://www.wikidata.org/entity/Q59047228

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@en

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@nl

type

Item

label

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@en

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@nl

prefLabel

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@en

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@nl

P1476

Effects of Atorvastatin on Ath ...... s Erythematosus: A Pilot Study

@en

P2093

José Delgado Alves

http://www.w3.org/2001/XMLSchema#string

Katharina Benita Sokoll

http://www.w3.org/2001/XMLSchema#string

Luis Romulo Lopez

http://www.w3.org/2001/XMLSchema#string

Paul Richard Julian Ames

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

Premature atherosclerosis in systemic lupus erythematosus.

Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis.

Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease.

Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome.

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

Risk factors for cardiovascular disease in systemic lupus erythematosus.

Oxidized low-density lipoprotein and atherosclerosis.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/295239

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Paul Emery

Joana R. Batuca

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049634296

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis